Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00703677 · ClinicalTrials.gov registry record · Phase 1
A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration
A Phase 1 study, sponsored by Westat.
- Completed
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
NCT00703677 is a Phase 1 study that has completed, run by Westat. The registered enrollment target is 17 participants.
The verdict
NCT00703677, a Phase 1 study, has completed, sponsored by Westat.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
The goal of this trial is to evaluate the safety and tolerability of lithium in people with progressive supranuclear palsy or corticobasal degeneration.
Interventions
- DRUG Lithium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2008-09 |
| Est. Completion | 2010-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00703677
The ClinicalTrials.gov registry entry for NCT00703677 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Westat, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lithium is the first listed.
NCT00703677 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00703677 about?
NCT00703677 is a clinical study titled "A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration". The goal of this trial is to evaluate the safety and tolerability of lithium in people with progressive supranuclear palsy or corticobasal degeneration.
What is the current status of trial NCT00703677?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2008-09. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00703677?
The interventions under investigation include: Lithium (DRUG).
Who is sponsoring clinical trial NCT00703677?
This trial is sponsored by Westat, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.